Brief: Acquisition Has Love Pharma’S Naltrexone On NIH Shortlist To Address Unmet Medical Need—Treatment For Long Covid

Jolt Health

03/11/2022 12:55

Nov 3 (Reuters) - Love Pharma Inc  LUV.CD :
    * ACQUISITION HAS LOVE PHARMA’S NALTREXONE ON NIH SHORTLIST
TO
ADDRESS UNMET MEDICAL NEED—TREATMENT FOR LONG COVID

Source text for Eikon:  ID:nGNXb3hFXX 
Further company coverage:  LUV.CD 
 ((Reuters.Briefs@thomsonreuters.com;))